6533b7dafe1ef96bd126f686

RESEARCH PRODUCT

Changes in the requirement for early surgery in inflammatory bowel disease in the era of biological agents.

Esther Garcia-planellaXavier CalvetAriadna ClosGeteccu-eneida RegistryJavier P. GisbertJordi GuardiolaMiguel MinguezAntonio López-sanrománSantiago García-lópezCarlos TaxoneraPilar NosFiorella CañeteIngrid OrdásRuth De FranciscoM Dolores Martín-arranzJesús BarrioEva Iglesias-floresRaquel CamargoMaria EsteveMontserrat GuaschEugeni DomènechLuisa De CastroMíriam MañosaMontserrat RiveroFernando GomollónIsabel Vera

subject

MaleTime FactorsDiseaseInflammatory bowel diseaseInflammatory bowel diseasesurgeryAnti-TNFBiological Factors0302 clinical medicineAnti-TNF Immunosuppressants Inflammatory bowel disease SurgeryCrohn DiseaseimmunosuppressantsRisk Factorsanti‐TNFGastroenterologyAge FactorsMiddle AgedUlcerative colitisNatural history030220 oncology & carcinogenesisCohort030211 gastroenterology & hepatologyFemaleImmunosuppressive AgentsCohort studyAdultmedicine.medical_specialtyMedicinaDisease-Free Survival03 medical and health sciencesEarly surgeryYoung AdultGastrointestinal Agentsinflammatory bowel diseaseInternal medicinemedicineHumansSurvival analysisRetrospective StudiesHepatologybusiness.industryTumor Necrosis Factor-alphamedicine.diseasedigestive system diseasesInfliximabImmunosuppressantsSurgeryColitis Ulcerativebusiness

description

This is the peer reviewed version of the following article: Changes in the requirement for early surgery in inflammatory bowel disease in the era of biological agents. Journal of Gastroenterology and Hepatology (2020): 29 April, which has been published in final form at https://doi.org/10.1111/jgh.15084. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions

yearjournalcountryeditionlanguage
2020-05-10
10.1111/jgh.15084https://hdl.handle.net/10668/15469